Eylea Market 2026 projected to reach $14.79 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Eylea Market During The Forecast Period 2026–2030?

The eylea market size has experienced significant expansion in recent years. It is projected to increase from $10.51 billion in 2025 to $11.15 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.2%. This historical growth can be attributed to factors such as the increasing prevalence of age-related macular degeneration, the aging global population, the strong clinical efficacy of anti-VEGF drugs, a rise in ophthalmology specialty centers, and comprehensive reimbursement support for retinal therapies.

The Eylea market is anticipated to experience robust expansion over the coming years. Its value is projected to reach $14.79 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast period can be primarily attributed to factors such as an expanding diabetic population, the broadening of its application to encompass more retinal disorders, advancements in developing long-acting formulations, enhancements in drug delivery methods, and greater market penetration in developing economies. Significant trends observed during this period include the development of extended-interval anti-VEGF treatments, a move towards the adoption of prefilled syringes, its increased application in treating diabetic retinopathy, a rise in intravitreal procedures performed in hospitals, and an emphasis on real-world data and patient outcomes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9155&type=smp

What Underlying Factors Are Accelerating The Growth Of The Eylea Market?

The Eylea market is anticipated to expand due to the growing occurrence of ocular diseases. These conditions are eye-related issues that impair the eye’s proper functioning, subsequently diminishing vision and clarity. Frequently, symptoms do not manifest until the disease has progressed significantly. Eylea is used to manage various ocular diseases, specifically wet age-related macular degeneration (AMD) and glaucoma, both of which cause damage to the retina or macula, thereby impacting vision. The medication functions by inhibiting the protein responsible for the formation of new, fragile blood vessels and by reducing retinal swelling resulting from blood vessel blockages. For example, data from the BrightFocus Foundation, a U.S. nonprofit dedicated to research on macular degeneration and glaucoma, indicates that in 2024, around 80 million individuals worldwide are affected by glaucoma, a figure expected to increase to 111 million by 2040. Consequently, the expanding incidence of ocular diseases is a key factor propelling the Eylea market.

What Market Segments Are Evaluated Within The Eylea Market?

The eylea market covered in this report is segmented –

1) By Product: Prefilled Syringe Package, Vial Package

2) By Disorder: Wet Age-Related Macular Degeneration (AMD), Diabetic Retinopathy, Other Disorders

3) By Application: Hospitals, Retail Pharmacy, Other Applications

Subsegments:

1) By Prefilled Syringe Package: Single-Dose Prefilled Syringes, Multi-Dose Prefilled Syringes

2) By Vial Package: Single-Dose Vials, Multi-Dose Vials

What Industry Trends Are Redefining The Eylea Market?

Leading companies in the eylea market are concentrating on developing biologic medications, such as aflibercept biosimilar, to secure a competitive advantage. An Aflibercept Biosimilar is a version of the reference drug aflibercept that is biologically similar, engineered to have no clinically significant differences, and offers a cost-effective option for addressing specific eye conditions. For example, in September 2023, Biocon Biologics Ltd., an India-based biopharmaceutical firm, obtained marketing authorization from the European Commission (EC) for YESAFILI, an Aflibercept biosimilar, within the European Union (EU). This approval was granted subsequent to a positive opinion issued by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in July. YESAFILI is an ophthalmology product formulated for the management of various eye conditions, and its authorization indicates its comparability in terms of quality, safety, and efficacy to the reference product Eylea (aflibercept).

Who Are The Top Market Participants Influencing The Eylea Market?

Major companies operating in the eylea market are Regeneron Pharmaceuticals Inc., Bayer AG, Novartis AG, Roche Holding AG, Pfizer Inc., Amgen Inc., Sanofi S.A., AbbVie Inc., Alcon Inc., Genentech Inc., Johnson & Johnson, Samsung Bioepis Co. Ltd., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Daiichi Sankyo Company Limited, Aerie Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Santen Pharmaceutical Co. Ltd., Allergan plc, BioMarin Pharmaceutical Inc.

Read the full eylea market report here:

https://www.thebusinessresearchcompany.com/report/eylea-global-market-report

Which Region Is Projected To Dominate The Eylea Market During The Forecast Period?

North America was the largest region in the eylea market in 2025. Asia-Pacific is expected to be the fastest-growing region in the eylea market during the forecast period. The regions covered in the eylea market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Eylea Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9155&type=smp

Browse Through More Reports Similar to the Global Eylea Market 2026, By The Business Research Company

Eylea Market Report 2026

https://www.thebusinessresearchcompany.com/report/eylea-global-market-report

Xylene Market Report 2026

https://www.thebusinessresearchcompany.com/report/xylene-global-market-report

Vanadium Market Report 2026

https://www.thebusinessresearchcompany.com/report/vanadium-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795